When was Sygnature Discovery founded?

Sygnature Discovery was founded in 2004 and raised its 1st funding round 13 years after it was founded.

Where is Sygnature Discovery located?

Sygnature Discovery is headquartered in Nottingham, United Kingdom.

Which legal entities is Sygnature Discovery associated with?

Sygnature Discovery is associated with SPARK TOPCO LIMITED and 2 others.

How many employees does Sygnature Discovery have?

As of Apr 30, 2026, the latest employee count at Sygnature Discovery is 639.

Is Sygnature Discovery a funded company?

Sygnature Discovery is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 09, 2017.

When was the latest funding round of Sygnature Discovery?

Sygnature Discovery's latest funding was a $***** Series A round on Jun 30, 2021, with participation from 1 investor. Its primary sector is Life Sciences Tech. In United Kingdom, the Life Sciences Tech sector has seen $2.24B in funding in 2026 to date.

Where does Sygnature Discovery rank among its competitors?

Sygnature Discovery ranks 5th amongst 162 active competitors, of which 18 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Novotech, which secured an undisclosed amount in Mar, 2025.

Who are the top competitors of Sygnature Discovery?

Sygnature Discovery's top competitors include Novotech, Concert AI and Bioptimus. Among them, Novotech secured the most recent funding round in March, 2025.

Sygnature Discovery - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of services and products for integrated drug discovery. The company undertakes hit identification, hit-to-lead, and lead optimization projects and complete drug discovery programs. Its core capabilities include medicinal chemistry, in vitro biosciences, computational sciences and informatics, DMPK/physical sciences, and project management.

Website: sygnaturediscovery.com
Social

Key Metrics

Founded Year

2004

Location

Nottingham, United Kingdom

Stage

Series A

Latest Funding Round

Series A, Jun 30, 2021, $*****

Investors

Rothschild & Co & 5 more

Ranked

5^th among 162 active competitors

Employee Count

639 as on Apr 30, 2026

Investment & Acquisitions

NuChem Sciences & 6 more

Similar Companies

Novotech & 187 more

View Sygnature Discovery's full profile

Sygnature Discovery is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
SYGNATURE DISCOVERY LIMITED CIN: 5210563 , Germany, Active	Aug 18, 2004	-	354 (As on Mar 31, 2021)
SPARK TOPCO LIMITED CIN: 13437427 , United Kingdom, Active		-	489 (As on Jan 31, 2022)
Ivanyuk Corporation s.r.o. CIN: 01834461 , Czech Republic, Active	Jul 03, 2013	-	-

Sygnature Discovery has raised funding over 2 rounds. Its first funding round was on Oct 09, 2017. Its latest funding round was a Series A round on Jun 30, 2021 for $*****. 1 investor participated in its latest round. Sygnature Discovery has 4 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Sygnature Discovery:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 30, 2021	7970415	Series A	4323294	3170432	9089642	4367340
Oct 09, 2017	4671868	Series A	4817323	1042709	5722443	Phoenix Equity Partners

Access funding benchmarks and valuations. Sign up today!

View details of Sygnature Discovery's funding rounds and investors

Sygnature Discovery's Board of Directors

Sygnature Discovery's board has 4 active members. Jonathan Gareth Williams, Louisa Jordison, Paul Overton and Simon Hirst are part of team.

Here is the list of Sygnature Discovery's board of directors:

Name	Type	Representing	Status	Duration
Simon Hirst	Team	-	Current	21y 10m
rmvwrwu	Team	-	Current	6y 8m
c{lzh{q	Team	-	Current	1y 3m
sqmpuue	Team	-	Current	4y 1m
{zxlehc	Team	-	Past	1y 7m
gvszeyu	Team	-	Past	8y 4m
xcf{tgb	Team	-	Past	8y 3m
bavmcxf	Independent board member	-	Past	5y 1m

Sygnature Discovery's employee count trend

Sygnature Discovery has 639 employees as of Apr 26. Here is Sygnature Discovery's employee count trend over the years:

Employee count trend for Sygnature Discovery

Uncover Sygnature Discovery's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sygnature Discovery include Novotech, Concert AI and Bioptimus. Here is the list of Top 10 competitors of Sygnature Discovery, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novotech 2002, Sydney (Australia), Acquired	Provider of clinical research services across all trial phases and therapeutic areas	$255M	GIC, Mubadala & 5 others	68/100
2nd	Concert AI 2018, Boston (United States), Series C	Provider of AI and real-world data solutions for life sciences	$300M	Sixth Street, Declaration Partners & 4 others	64/100
3rd	Bioptimus 2024, Paris (France), Series A	Developer of AI foundation model to transform biological research	$76M	Cathay Innovation, Sofinnova Partners & 15 others	62/100
4th	Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired	AI powered scientific data management and workflow automation solutions	$11.3M	Scottish Equity Partners, Insight Partners ... & 4 others	62/100
5th	Sygnature Discovery 2004, Nottingham (United Kingdom), Series A	Provider of services and products for integrated drug discovery	-	Rothschild & Co, Torreal & 4 others	56/100
6th	Digital Science 2010, London (United Kingdom), Funding Raised	Research assistance software solutions	-	HHS	56/100
7th	Doctor Evidence 2004, Santa Monica (United States), Acquired	Evidence based medical decision solutions for multiple healthcare stakeholders	$1.5M	Wormhole Capital, Costella Kirsch	56/100
8th	Instem 1969, Conshohocken (United States), Acquired	Software solutions for data collection, management, and analysis for the life science industry	-	Eiffel Investment Group, Europa & 1 others	55/100
9th	Intelligencia 2018, New York City (United States), Series A	Cloud and AI-led analytics platform for drug discovery and development	$13.8M	MTIP, By The Tower & 5 others	52/100
10th	Anju Software 2015, New York City (United States), Acquired	Life science software platform	$27.4M	Providence Equity Partners, PSG	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Sygnature Discovery's competitors? Click here to see the top ones

Sygnature Discovery has made 2 investments in companies including Step Pharma and Peak Proteins. Sygnature Discovery has also acquired 5 companies including NuChem Sciences and Peak Proteins.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 31, 2023	Acquisition	NuChem Sciences	2011	Saint-laurent (Canada)
Apr 01, 2022	Acquisition	Peak Proteins	2015	Alderley Edge (United Kingdom)
Jun 03, 2020	Acquisition	Alderley Park	2013	Macclesfield (United Kingdom)